J. M. Webster

发表

Small-Animal PET Imaging of Human Epidermal Growth Factor Receptor Type 2 Expression with Site-Specific 18F-Labeled Protein Scaffold Molecules

S. Gambhir, A. De, M. Namavari, 2008, Journal of Nuclear Medicine.

Bortezomib rapidly suppresses ubiquitin thiolesterification to ubiquitin-conjugating enzymes and inhibits ubiquitination of histones and type I inositol 1,4,5-trisphosphate receptor.

R. Wojcikiewicz, J. M. Webster, Qun Xu, 2004, Molecular cancer therapeutics.

A 2-Helix Small Protein Labeled with 68Ga for PET Imaging of HER2 Expression

S. Gambhir, F. Syud, Zhen Cheng, 2009, Journal of Nuclear Medicine.

N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits ligand binding to certain G protein-coupled receptors.

R. Wojcikiewicz, J. M. Webster, M. Bentley, 2003, European journal of pharmacology.

Inositol 1,4,5-Trisphosphate Receptor Ubiquitination Is Mediated by Mammalian Ubc7, a Component of the Endoplasmic Reticulum-associated Degradation Pathway, and Is Inhibited by Chelation of Intracellular Zn2+*

R. Wojcikiewicz, A. Weissman, J. M. Webster, 2003, Journal of Biological Chemistry.

Hsp90 activator Aha1 drives production of pathological tau aggregates

B. Blagg, J. Koren, D. Zheng, 2017, Proceedings of the National Academy of Sciences.

Small Heat Shock Proteins, Big Impact on Protein Aggregation in Neurodegenerative Disease

V. Uversky, April L Darling, L. Blair, 2019, Front. Pharmacol..

Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies.

J. Marsh, L. Thompson, J. Huston, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Down-regulation of types I, II and III inositol 1,4,5-trisphosphate receptors is mediated by the ubiquitin/proteasome pathway.

R. Wojcikiewicz, J. Oberdorf, J. M. Webster, 1999, The Biochemical journal.

Isoform-selective Hsp90 inhibition rescues model of hereditary open-angle glaucoma

C. Passaglia, B. Blagg, J. Koren, 2017, Scientific Reports.

Ubiquitination and Proteasomal Degradation of Endogenous and Exogenous Inositol 1,4,5-Trisphosphate Receptors in αT3-1 Anterior Pituitary Cells*

R. Wojcikiewicz, Chen Gao, K. Alzayady, 2003, The Journal of Biological Chemistry.

Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody.

David W. Colby, Martin L. Duennwald, S. Lindquist, 2004, Proceedings of the National Academy of Sciences of the United States of America.

In vivo targeting of HER2-positive tumor using 2-helix affibody molecules

S. Gambhir, F. Syud, Zhen Cheng, 2012, Amino Acids.

Hsp22 with an N-Terminal Domain Truncation Mediates a Reduction in Tau Protein Levels

P. Bickford, V. Uversky, C. Dickey, 2020, International journal of molecular sciences.

Development of a human light chain variable domain (V(L)) intracellular antibody specific for the amino terminus of huntingtin via yeast surface display.

K Dane Wittrup, Payal Garg, David W. Colby, 2004, Journal of molecular biology.

64Cu-Labeled Affibody Molecules for Imaging of HER2 Expressing Tumors

Jinha M. Park, S. Gambhir, A. De, 2010, Molecular Imaging and Biology.

Engineered Two‐Helix Small Proteins for Molecular Recognition

S. Gambhir, F. Syud, Zhen Cheng, 2009, Chembiochem : a European journal of chemical biology.

A novel 18F-labeled two-helix scaffold protein for PET imaging of HER2-positive tumor

S. Gambhir, M. Namavari, F. Syud, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

Benzothiazole Substitution Analogs of Rhodacyanine Hsp70 Inhibitors Modulate Tau Accumulation.

C. Dickey, S. Hill, April L Darling, 2023, ACS chemical biology.

Isoform-selective Hsp90 inhibition rescues model of hereditary open-angle glaucoma

C. Passaglia, B. Blagg, J. Koren, 2017, Scientific Reports.

In vivo targeting of HER2-positive tumor using 2-helix affibody molecules

S. Gambhir, F. Syud, Zhen Cheng, 2011, Amino Acids.